| Primary |
| Heparin Neutralisation Therapy |
42.9% |
| Anticoagulant Therapy |
14.3% |
| Heart Valve Replacement |
14.3% |
| Open Heart Surgery |
14.3% |
| Toxicity To Various Agents |
14.3% |
|
| Product Quality Issue |
20.0% |
| Cerebral Disorder |
10.0% |
| Hypotension |
10.0% |
| Oxygen Saturation Decreased |
10.0% |
| Right Ventricular Failure |
10.0% |
| Swelling |
10.0% |
| Thrombosis In Device |
10.0% |
| Unresponsive To Stimuli |
10.0% |
| Urticaria |
10.0% |
|
| Secondary |
| Prosthesis Implantation |
18.4% |
| Product Used For Unknown Indication |
17.2% |
| Anticoagulant Therapy |
9.2% |
| Antiplatelet Therapy |
9.2% |
| Maintenance Of Anaesthesia |
9.2% |
| Induction Of Anaesthesia |
6.9% |
| Aortic Surgery |
5.7% |
| Surgery |
4.6% |
| Circulatory Collapse |
3.4% |
| Heparin Neutralisation Therapy |
3.4% |
| Blood Pressure Abnormal |
2.3% |
| Haemorrhagic Disorder |
2.3% |
| Anaesthesia |
1.1% |
| Antibiotic Prophylaxis |
1.1% |
| Aortic Valve Replacement |
1.1% |
| Atrial Fibrillation |
1.1% |
| Open Heart Surgery |
1.1% |
| Prophylaxis |
1.1% |
| Unevaluable Event |
1.1% |
|
| Systemic Inflammatory Response Syndrome |
23.1% |
| Muscular Weakness |
15.4% |
| Hypoxia |
7.7% |
| Intestinal Ischaemia |
7.7% |
| Pain |
7.7% |
| Product Quality Issue |
7.7% |
| Transaminases Increased |
7.7% |
| Type I Hypersensitivity |
7.7% |
| Urticaria |
7.7% |
| Urticaria Generalised |
7.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.7% |
| Coronary Artery Bypass |
19.3% |
| Aortic Valve Replacement |
6.1% |
| Catheterisation Cardiac |
4.0% |
| Mitral Valve Replacement |
3.9% |
| Prophylaxis |
3.0% |
| Surgery |
2.5% |
| Mitral Valve Repair |
2.1% |
| Hypertension |
1.8% |
| Malignant Melanoma Stage Iii |
1.3% |
| Coronary Artery Bypass Graft |
1.2% |
| Cox-maze Procedure |
1.2% |
| Tricuspid Valve Repair |
1.2% |
| Gastric Cancer |
1.0% |
| Anticoagulant Therapy |
0.9% |
| Diabetes Mellitus |
0.9% |
| Acute Coronary Syndrome |
0.8% |
| Cardiac Operation |
0.8% |
| Sternotomy |
0.8% |
| Aortic Dissection |
0.7% |
|
| Pain |
14.2% |
| Unevaluable Event |
12.0% |
| Fear |
9.0% |
| Injury |
8.6% |
| Anhedonia |
7.3% |
| Stress |
6.9% |
| Renal Failure |
6.0% |
| Anxiety |
5.6% |
| Renal Injury |
5.6% |
| Emotional Distress |
4.3% |
| Renal Failure Acute |
4.3% |
| Renal Impairment |
3.0% |
| Death |
2.1% |
| Depression |
2.1% |
| Renal Tubular Necrosis |
2.1% |
| Cerebrovascular Accident |
1.7% |
| Renal Failure Chronic |
1.7% |
| Cellulitis |
1.3% |
| Respiratory Failure |
1.3% |
| Mental Disorder |
0.9% |
|
